Is Xenon Pharmaceuticals Inc. (XENE) a Buy, Sell, or Hold?
Xenon Pharmaceuticals Inc.
NASDAQ:XENE
$67.3 USD
-$0.42 (-0.62%)
- Volume
- 1.05M
- Average Volume
- 1.41M
- Market Capitalization
- $5.31B
- P/E Ratio
- -14.32
- Dividend Yield
- 0.00%
- Price Target
- $89.50
- Year High
- $72.66
- Year Low
- $30.00
- Day High
- —
- Day Low
- —
- Payout Ratio
- $0.00
- Current Ratio
- $27.79
NUMBER OF INSIDERS BUYING (LAST 12 MONTHS)
63
NUMBER OF INSIDERS SELLING (LAST 12 MONTHS)
46
AMOUNT OF INSIDER SELLING (LAST 12 MONTHS)
$ 807K
XENE Estimated and Actual Revenue by Quarter
Get MSFT Insider Trade Alerts
XENE Insider Trading History
| Insider Name | Title | Date | Transaction | Cost | Filing Date |
|---|---|---|---|---|---|
| PATOU GARY | director | 2026-06-05 | S-Sale | 53.14 | 2026-06-08 |
| Cannon Gillian | director | 2026-06-05 | S-Sale | 53.14 | 2026-06-08 |
| PATOU GARY | director | 2026-06-01 | M-Exempt | 0 | 2026-06-03 |
| PATOU GARY | director | 2026-06-03 | A-Award | 53.46 | 2026-06-03 |
| PATOU GARY | director | 2026-06-03 | A-Award | 0 | 2026-06-03 |
| PATOU GARY | director | 2026-06-01 | M-Exempt | 0 | 2026-06-03 |
| Machado Patrick | director | 2026-06-03 | A-Award | 53.46 | 2026-06-03 |
| Machado Patrick | director | 2026-06-01 | M-Exempt | 0 | 2026-06-03 |
| Machado Patrick | director | 2026-06-03 | A-Award | 0 | 2026-06-03 |
| Machado Patrick | director | 2026-06-01 | M-Exempt | 0 | 2026-06-03 |
| Gover Justin D. | director | 2026-06-03 | A-Award | 53.46 | 2026-06-03 |
| Gover Justin D. | director | 2026-06-01 | M-Exempt | 0 | 2026-06-03 |
| Gover Justin D. | director | 2026-06-03 | A-Award | 0 | 2026-06-03 |
| Gover Justin D. | director | 2026-06-01 | M-Exempt | 0 | 2026-06-03 |
| GAROFALO ELIZABETH A. | director | 2026-06-03 | A-Award | 53.46 | 2026-06-03 |
| GAROFALO ELIZABETH A. | director | 2026-06-01 | M-Exempt | 0 | 2026-06-03 |
| GAROFALO ELIZABETH A. | director | 2026-06-03 | A-Award | 0 | 2026-06-03 |
| GAROFALO ELIZABETH A. | director | 2026-06-01 | M-Exempt | 0 | 2026-06-03 |
| GANNON STEVEN | director | 2026-06-01 | M-Exempt | 0 | 2026-06-03 |
| GANNON STEVEN | director | 2026-06-01 | F-InKind | 53.41 | 2026-06-03 |
| GANNON STEVEN | director | 2026-06-03 | A-Award | 53.46 | 2026-06-03 |
| GANNON STEVEN | director | 2026-06-03 | A-Award | 0 | 2026-06-03 |
| GANNON STEVEN | director | 2026-06-01 | M-Exempt | 0 | 2026-06-03 |
| Cannon Gillian | director | 2026-06-03 | A-Award | 53.46 | 2026-06-03 |
| Cannon Gillian | director | 2026-06-01 | M-Exempt | 0 | 2026-06-03 |
| Cannon Gillian | director | 2026-06-03 | A-Award | 0 | 2026-06-03 |
| Cannon Gillian | director | 2026-06-01 | M-Exempt | 0 | 2026-06-03 |
| Svoronos Dawn | director | 2026-06-01 | M-Exempt | 0 | 2026-06-03 |
| Svoronos Dawn | director | 2026-06-01 | F-InKind | 53.41 | 2026-06-03 |
| Svoronos Dawn | director | 2026-06-03 | A-Award | 53.46 | 2026-06-03 |
| Svoronos Dawn | director | 2026-06-03 | A-Award | 0 | 2026-06-03 |
| Svoronos Dawn | director | 2026-06-01 | M-Exempt | 0 | 2026-06-03 |
| GANNON STEVEN | director | 2026-05-12 | M-Exempt | 7.38 | 2026-05-13 |
| GANNON STEVEN | director | 2026-05-12 | M-Exempt | 7.38 | 2026-05-13 |
| KENNEY CHRISTOPHER JOHN | officer: Chief Medical Officer | 2026-03-12 | M-Exempt | 0 | 2026-03-13 |
| KENNEY CHRISTOPHER JOHN | officer: Chief Medical Officer | 2026-03-12 | M-Exempt | 0 | 2026-03-13 |
| KENNEY CHRISTOPHER JOHN | officer: Chief Medical Officer | 2026-03-13 | S-Sale | 55.225 | 2026-03-13 |
| DiFabio Andrea | officer: Chief Legal Officer | 2026-03-12 | M-Exempt | 0 | 2026-03-13 |
| DiFabio Andrea | officer: Chief Legal Officer | 2026-03-12 | M-Exempt | 0 | 2026-03-13 |
| DiFabio Andrea | officer: Chief Legal Officer | 2026-03-13 | S-Sale | 55.225 | 2026-03-13 |
| MORTIMER IAN | director, officer: PRESIDENT & CEO | 2026-03-12 | M-Exempt | 0 | 2026-03-13 |
| MORTIMER IAN | director, officer: PRESIDENT & CEO | 2026-03-12 | M-Exempt | 0 | 2026-03-13 |
| MORTIMER IAN | director, officer: PRESIDENT & CEO | 2026-03-13 | S-Sale | 55.225 | 2026-03-13 |
| KENNEY CHRISTOPHER JOHN | officer: Chief Medical Officer | 2026-03-09 | M-Exempt | 0 | 2026-03-11 |
| KENNEY CHRISTOPHER JOHN | officer: Chief Medical Officer | 2026-03-09 | A-Award | 0 | 2026-03-11 |
| KENNEY CHRISTOPHER JOHN | officer: Chief Medical Officer | 2026-03-10 | S-Sale | 60.108 | 2026-03-11 |
| KENNEY CHRISTOPHER JOHN | officer: Chief Medical Officer | 2026-03-09 | M-Exempt | 0 | 2026-03-11 |
| DiFabio Andrea | officer: Chief Legal Officer | 2026-03-09 | M-Exempt | 0 | 2026-03-11 |
| DiFabio Andrea | officer: Chief Legal Officer | 2026-03-09 | A-Award | 0 | 2026-03-11 |
| DiFabio Andrea | officer: Chief Legal Officer | 2026-03-10 | S-Sale | 60.108 | 2026-03-11 |
| DiFabio Andrea | officer: Chief Legal Officer | 2026-03-09 | M-Exempt | 0 | 2026-03-11 |
| MORTIMER IAN | director, officer: PRESIDENT & CEO | 2026-03-09 | M-Exempt | 4.75 | 2026-03-11 |
| MORTIMER IAN | director, officer: PRESIDENT & CEO | 2026-03-09 | M-Exempt | 8.4 | 2026-03-11 |
| MORTIMER IAN | director, officer: PRESIDENT & CEO | 2026-03-09 | S-Sale | 59.26 | 2026-03-11 |
| MORTIMER IAN | director, officer: PRESIDENT & CEO | 2026-03-09 | M-Exempt | 9.44 | 2026-03-11 |
| MORTIMER IAN | director, officer: PRESIDENT & CEO | 2026-03-09 | S-Sale | 58.81 | 2026-03-11 |
| MORTIMER IAN | director, officer: PRESIDENT & CEO | 2026-03-09 | M-Exempt | 3.1 | 2026-03-11 |
| MORTIMER IAN | director, officer: PRESIDENT & CEO | 2026-03-09 | S-Sale | 59.88 | 2026-03-11 |
| MORTIMER IAN | director, officer: PRESIDENT & CEO | 2026-03-09 | M-Exempt | 0 | 2026-03-11 |
| MORTIMER IAN | director, officer: PRESIDENT & CEO | 2026-03-09 | A-Award | 0 | 2026-03-11 |
| MORTIMER IAN | director, officer: PRESIDENT & CEO | 2026-03-09 | S-Sale | 59.5 | 2026-03-11 |
| MORTIMER IAN | director, officer: PRESIDENT & CEO | 2026-03-10 | S-Sale | 60.108 | 2026-03-11 |
| MORTIMER IAN | director, officer: PRESIDENT & CEO | 2026-03-09 | S-Sale | 60.47 | 2026-03-11 |
| MORTIMER IAN | director, officer: PRESIDENT & CEO | 2026-03-09 | S-Sale | 62.06 | 2026-03-11 |
| MORTIMER IAN | director, officer: PRESIDENT & CEO | 2026-03-09 | S-Sale | 61.26 | 2026-03-11 |
| MORTIMER IAN | director, officer: PRESIDENT & CEO | 2026-03-09 | S-Sale | 60.08 | 2026-03-11 |
| MORTIMER IAN | director, officer: PRESIDENT & CEO | 2026-03-09 | S-Sale | 60.49 | 2026-03-11 |
| MORTIMER IAN | director, officer: PRESIDENT & CEO | 2026-03-09 | M-Exempt | 0 | 2026-03-11 |
| MORTIMER IAN | director, officer: PRESIDENT & CEO | 2026-03-09 | M-Exempt | 8.4 | 2026-03-11 |
| MORTIMER IAN | director, officer: PRESIDENT & CEO | 2026-03-09 | M-Exempt | 3.1 | 2026-03-11 |
| MORTIMER IAN | director, officer: PRESIDENT & CEO | 2026-03-09 | M-Exempt | 4.75 | 2026-03-11 |
| MORTIMER IAN | director, officer: PRESIDENT & CEO | 2026-03-09 | M-Exempt | 9.44 | 2026-03-11 |
| KENNEY CHRISTOPHER JOHN | officer: Chief Medical Officer | 2026-01-09 | A-Award | 42.15 | 2026-01-09 |
| KENNEY CHRISTOPHER JOHN | officer: Chief Medical Officer | 2026-01-09 | A-Award | 0 | 2026-01-09 |
| Cline Darren S | officer: Chief Commercial Officer | 2026-01-09 | A-Award | 42.15 | 2026-01-09 |
| Cline Darren S | officer: Chief Commercial Officer | 2026-01-09 | A-Award | 0 | 2026-01-09 |
| DiFabio Andrea | officer: Chief Legal Officer | 2026-01-09 | A-Award | 42.15 | 2026-01-09 |
| DiFabio Andrea | officer: Chief Legal Officer | 2026-01-09 | A-Award | 0 | 2026-01-09 |
| MORTIMER IAN | director, officer: PRESIDENT & CEO | 2026-01-09 | A-Award | 42.15 | 2026-01-09 |
| MORTIMER IAN | director, officer: PRESIDENT & CEO | 2026-01-09 | A-Award | 0 | 2026-01-09 |
| MORTIMER IAN | director, officer: PRESIDENT & CEO | 2026-01-02 | M-Exempt | 7.49 | 2026-01-02 |
| MORTIMER IAN | director, officer: PRESIDENT & CEO | 2026-01-02 | S-Sale | 44.4 | 2026-01-02 |
| MORTIMER IAN | director, officer: PRESIDENT & CEO | 2026-01-02 | S-Sale | 44.93 | 2026-01-02 |
| MORTIMER IAN | director, officer: PRESIDENT & CEO | 2026-01-02 | M-Exempt | 7.49 | 2026-01-02 |
| MORTIMER IAN | director, officer: PRESIDENT & CEO | 2025-12-05 | S-Sale | 45.03 | 2025-12-09 |
| MORTIMER IAN | director, officer: PRESIDENT & CEO | 2025-12-08 | S-Sale | 45.59 | 2025-12-09 |
| MORTIMER IAN | director, officer: PRESIDENT & CEO | 2025-12-08 | S-Sale | 46.32 | 2025-12-09 |
| MORTIMER IAN | director, officer: PRESIDENT & CEO | 2025-11-28 | S-Sale | 45.01 | 2025-12-03 |
| Kelly Thomas Patrick | officer: Chief Financial Officer | 2025-10-15 | A-Award | 41.9 | 2025-10-17 |
| Kelly Thomas Patrick | officer: Chief Financial Officer | 2025-10-15 | A-Award | 0 | 2025-10-17 |
| Kelly Thomas Patrick | officer: Chief Financial Officer | 2025-10-15 | 0 | 2025-10-17 | |
| MORTIMER IAN | director, officer: PRESIDENT, CEO & INTERIM CFO | 2025-10-01 | M-Exempt | 7.69 | 2025-10-01 |
| MORTIMER IAN | director, officer: PRESIDENT, CEO & INTERIM CFO | 2025-10-01 | S-Sale | 40.16 | 2025-10-01 |
| MORTIMER IAN | director, officer: PRESIDENT, CEO & INTERIM CFO | 2025-10-01 | M-Exempt | 7.69 | 2025-10-01 |
| Cline Darren S | officer: Chief Commercial Officer | 2025-06-23 | A-Award | 31.49 | 2025-06-24 |
| Cline Darren S | officer: Chief Commercial Officer | 2025-06-23 | 0 | 2025-06-24 | |
| PATOU GARY | director | 2025-06-05 | A-Award | 30.73 | 2025-06-06 |
| PATOU GARY | director | 2025-06-05 | A-Award | 0 | 2025-06-06 |
| Machado Patrick | director | 2025-06-05 | A-Award | 30.73 | 2025-06-06 |
| Machado Patrick | director | 2025-06-05 | A-Award | 0 | 2025-06-06 |